Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» solid tumors
solid tumors
Intensity Therapeutics signs clinical collaboration agreement with Bristol Myers Squibb for advanced solid tumors
Pharmaceutical Business Review
Wed, 04/15/20 - 10:47 am
Bristol-Myers Squibb
Intensity Therapeutics
INT230-6
Yervoy
solid tumors
One of the best connected biotech startups in Boston snags a plum discovery deal with Novartis
Endpoints
Wed, 04/15/20 - 10:39 am
Novartis
drug discovery
solid tumors
immuno-oncology
Boston
startups
TScan
Harbour BioMed gets FDA nod to begin clinical trial for HBM4003 in cancer
Pharmaceutical Business Review
Mon, 03/2/20 - 09:39 am
Harbor BioMed
FDA
HBM4003
clinical trials
solid tumors
cancer
GSK pays $50M for 2 solid tumor cell therapies from Immatics
Pharmaceutical Business Review
Thu, 02/20/20 - 10:23 am
GSK
solid tumors
cell therapies
Immatics
MaaT bags €18M to test microbiome modulators in cancer patients
Fierce Biotech
Wed, 02/5/20 - 10:15 am
MaaT Pharma
solid tumors
graft vs host disease
Merck KGaA spinout iOnctura raises cash for cancer trials
Fierce Biotech
Thu, 01/23/20 - 11:59 am
Merck KGaA
iOnctura
clinical trials
IOA-244
cancer
solid tumors
Gritstone posts 'one of the most potent immunogenic-responses for a neoantigen vaccine'
Fierce Biotech
Fri, 12/13/19 - 09:19 pm
Gritstone Oncology
solid tumors
vaccines
neoantigens
Another cancer vaccine play out of Geneva shoots for 'hard endpoint' in PhII head and neck cancer test
Endpoints
Tue, 11/26/19 - 10:32 am
MaxiVAX
cancer
vaccines
cancer vaccines
solid tumors
head and neck cancer
Kiadis dumps phase 3 drug, halves head count in pivot to NK cells
Fierce Biotech
Wed, 11/13/19 - 09:57 am
Kiadis
clinical trials
ATIR101
solid tumors
Daiichi Sankyo initiates clinical trial of DS-7300 in collaboration with Sarah Cannon Research Institute
Pharmaceutical Business Review
Fri, 11/1/19 - 10:35 am
Daiichi Sankyo
Sarah Cannon Research Institute
antibody-drug conjugate
DS-7300
clinical trials
solid tumors
Forbius completes enrollment into phase 1a solid tumour trial of AVID200
Pharmaceutical Business Review
Tue, 10/15/19 - 11:01 am
Forbius
fibrosis
cancer
AVID200
solid tumors
clinical trials
Led by BioNTech, six biotechs line up for October IPOs
Endpoints
Sat, 09/28/19 - 04:38 pm
IPOs
MRNA
melanoma
inebilizumab
NMOSD
blood cancer
solid tumors
BioNTech
ADC Therapeutics
Viela Bio
Frequency Therapeutics
Aprea Therapeutics
Monopar Therapeutics
Deepening US footprint, AstraZeneca-partnered French biotech Innate shoots for $100M IPO
Endpoints
Mon, 09/23/19 - 10:49 am
Innate Pharma
IPOs
AstraZeneca
blood cancer
solid tumors
Achilles raises £100M for personalized T cell solid tumor trials
Fierce Biotech
Tue, 09/3/19 - 10:52 am
Achilles Therapeutics
solid tumors
CAR-T
Guardant’s blood test tracks microsatellite instability status on par with tissue biopsy in new study
Fierce Biotech
Mon, 08/5/19 - 10:05 am
Guardant Health
biomarkers
diagnostics
DNA
cancer
solid tumors
Lilly drops PD-L1/TIM-3 bispecific from clinical pipeline
Fierce Biotech
Tue, 07/30/19 - 11:23 am
Eli Lilly
bispecific antibodies
solid tumors
A personalized CAR-T to attack every solid tumor? Pact Pharma has a plan
Fierce Biotech
Mon, 07/22/19 - 08:05 pm
Pact Pharma
CAR-T
UCLA
solid tumors
personalized medicine
Boosting CAR-T to treat solid tumors with a vaccine
Fierce Biotech
Thu, 07/11/19 - 05:22 pm
vaccines
CAR-T
cancer
cancer vaccines
Elicio
solid tumors
Mirati and Novartis Pair Up to Evaluate Drug Combinations to Target KRAS G12C Mutations
BioSpace
Thu, 07/11/19 - 09:52 am
Mirati Therapeutics
Novartis
KRAS
solid tumors
Century Therapeutics Launches with $250 Million for Induced Pluripotent Stem Cell Platform
BioSpace
Tue, 07/2/19 - 10:22 am
Century Therapeutics
Versant Ventures
iPSC
solid tumors
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
next ›
last »